Search Results - "Véronique Bianco"

Antibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents by Quiambao, Beatriz P., Bavdekar, Ashish, Dubey, Anand Prakash, Jain, Hemant, Kolhe, Devayani, Bianco, Véronique, Miller, Jacqueline M., Van der Wielen, Marie

“…Long-term protection against meningococcal disease relies on antibody persistence after vaccination. We report antibody persistence up to 5 y after vaccination…”
Get full text

A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years by Borja-Tabora, Charissa Fay Corazon, Peyrani, Paula, Webber, Chris, Van der Wielen, Marie, Cheuvart, Brigitte, De Schrevel, Nathalie, Bianco, Veronique, Aris, Emmanuel, Cutler, Mark, Li, Ping, Perez, John L

“…A previous phase 2 study demonstrated the immunogenicity of a single dose of meningococcal A, C, W, Y-tetanus toxoid conjugate (MenACWY-TT) or polysaccharide…”
Get full text

Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis by Curran, Desmond, Hunjan, Manjit, El Ghachi, Amale, El-Hahi, Yassine, Bianco, Veronique, Ferreira, Germano

“…ObjectiveIndividuals with immunocompromised (IC) conditions are at a higher risk of developing herpes zoster (HZ) than IC-free individuals. This study assessed…”
Get full text

Meningococcal Polysaccharide A O-Acetylation Levels Do Not Impact the Immunogenicity of the Quadrivalent Meningococcal Tetanus Toxoid Conjugate Vaccine: Results from a Randomized, Controlled Phase III Study of Healthy Adults Aged 18 to 25 Years by Lupisan, Socorro, Limkittikul, Kriengsak, Sosa, Nestor, Chanthavanich, Pornthep, Bianco, Véronique, Baine, Yaela, Van der Wielen, Marie, Miller, Jacqueline M

“…OA  Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2–10-year-old children: results of an open, randomised, controlled study by Knuf, Markus, Romain, Olivier, Kindler, Klaus, Walther, Uta, Tran, Phu-My, Pankow-Culot, Heidemarie, Fischbach, Thomas, Kieninger-Baum, Dorothee, Bianco, Véronique, Baine, Yaela, Miller, Jacqueline

“…In Europe, the introduction of monovalent meningococcal serogroup C (MenC) conjugate vaccines has resulted in a significant decline in MenC invasive disease…”
Get full text

Burden of Herpes Zoster in the Japanese Population with Immunocompromised/Chronic Disease Conditions: Results from a Cohort Study Claims Database from 2005–2014 by Imafuku, Shinichi, Matsuki, Taizo, Mizukami, Akiko, Goto, Yasushi, de Souza, Sabrina, Jégou, Céline, Bianco, Veronique, Rosillon, Dominique, Ito, Chie, Curran, Desmond, Holl, Katsiaryna

“…Introduction The aim of this study is to describe the disease burden and costs of herpes zoster (HZ) in the general adult Japanese population or patients with…”
Get full text

A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2–10 y by Marie Van der Wielen, Jacqueline M. Miller, Timo Vesikari, Aino Forstén, Dominique Boutriau, Véronique Bianco

“…Incidence of meningococcal diseases is high in children, and effective vaccines are needed for this age group. In this phase II, open, controlled study, 309…”
Get full text

Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children by Knuf, Markus, Baine, Yaela, Bianco, Véronique, Boutriau, Dominique, Miller, Jacqueline M.

“…The present extension study, conducted in children originally vaccinated at 12-14 mo or 3-5 y of age, assessed antibody persistence and immune memory induced…”
Get full text

Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers by Vesikari, Timo, Forstén, Aino, Boutriau, Dominique, Bianco, Véronique, Van der Wielen, Marie, Miller, Jacqueline M.

“…Effective vaccines offering broad protection to toddlers, who are at high risk for invasive meningococcal disease, are needed. Here, the immunogenicity, safety…”
Get full text

The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine: A randomized, controlled non-inferiority study by Dbaibo, Ghassan, Macalalad, Noel, Reyes, Mari Rose Aplasca-De Los, Dimaano, Efren, Bianco, Véronique, Baine, Yaela, Miller, Jacqueline M.

“…Immunogenicity and safety of ACWY-TT compared with licensed ACWY polysaccharide vaccine (MenPS) in healthy adults, and lot-to-lot consistency of three ACWY-TT…”
Get full text

Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents by Quiambao, Beatriz P., Jain, Hermant, Bavdekar, Ashish, Dubey, Anand Prakash, Kolhe, Devayani, Bianco, Véronique, Van der Wielen, Marie, Miller, Jacqueline M.

“…Invasive meningococcal disease is a serious infection that is most often vaccine-preventable. Long-term protection relies on antibody persistence. Here we…”
Get full text

Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults by Bermal, Nancy, Huang, Li-Min, Dubey, AP, Jain, Hermant, Bavdekar, Ashish, Lin, Tzou-Yien, Bianco, Veronique, Baine, Yaela, Miller, Jacqueline M.

“…The highest incidence of invasive meningococcal disease is in young children, with a second peak in adolescents/young adults. All five major disease-causing…”
Get full text

The investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) and the seasonal influenza virus vaccine are immunogenic and well-tolerated when co-administered in adults by Reyes, Mari Rose Aplasca-De Los, Dimaano, Efren, Macalalad, Noel, Dbaibo, Ghassan, Bianco, Véronique, Baine, Yaela, Miller, Jacqueline M.

“…Co-administration of meningococcal serogroups A, C, W-135 and Y conjugate vaccine (ACWY-TT) with seasonal influenza vaccine was investigated in a subset of…”
Get full text

Persistence clinical studies: Can you believe what you see? by Cheuvart, Brigitte, Bianco, Véronique, Caubet, Magalie, Douha, Martine, Fissette, Laurence, François, Nancy, Sumbul, Anne

“…Long-term immunity, evaluated by the persistence of antibody titers, is important to assess duration of protection induced by vaccination. This paper aims at…”
Get full text

Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers by Timo Vesikari, Aino Forstén, Dominique Boutriau, Marie Van der Wielen, Jacqueline M. Miller, Véronique Bianco

“…Effective vaccines offering broad protection to toddlers, who are at high risk for invasive meningococcal disease, are needed. Here, the immunogenicity, safety…”
Get full text

A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 years by Vesikari, Timo, Forstén, Aino, Boutriau, Dominique, Bianco, Véronique, Van der Wielen, Marie, Miller, Jacqueline M.

“…Incidence of meningococcal diseases is high in children, and effective vaccines are needed for this age group. In this phase II, open, controlled study, 309…”
Get full text

Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles–mumps–rubella–varicella vaccine during the second year of life: An open, randomized controlled trial by Vesikari, Timo, Karvonen, Aino, Bianco, Veronique, Van der Wielen, Marie, Miller, Jacqueline

“…Abstract Co-administration of meningococcal ACWY-tetanus toxoid conjugate vaccine (ACWY-TT) with MMRV vaccine was investigated in 1000 12–23-month old children…”
Get full text

Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000–2012 by Yanni, Emad A., Ferreira, Germano, Guennec, Morgane, El Hahi, Yassine, El Ghachi, Amale, Haguinet, François, Espie, Emmanuelle, Bianco, Veronique

“…ObjectivesHerpes zoster (HZ) is caused by reactivation of varicella-zoster virus which remains latent in individuals after a varicella infection. It is…”
Get full text

Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines by Vesikari, Timo, Forsten, Aino, Bianco, Veronique, Van der Wielen, Marie, Miller, Jacqueline M

“…We evaluated safety, immunogenicity and antibody persistence of meningococcal serogroups A, C, W and Y tetanus toxoid conjugate vaccine (MenACWY-TT) booster…”
Get full text

Incidence of Respiratory Syncytial Virus Lower Respiratory Tract Infections During the First 2 Years of Life: A Prospective Study Across Diverse Global Settings by Langley, Joanne M, Bianco, Veronique, Domachowske, Joseph B, Madhi, Shabir A, Stoszek, Sonia K, Zaman, Khalequ, Bueso, Agustin, Ceballos, Ana, Cousin, Luis, D’Andrea, Ulises, Dieussaert, Ilse, Englund, Janet A, Gandhi, Sanjay, Gruselle, Olivier, Haars, Gerco, Jose, Lisa, Klein, Nicola P, Leach, Amanda, Maleux, Koen, Nguyen, Thi Lien Anh, Puthanakit, Thanyawee, Silas, Peter, Tangsathapornpong, Auchara, Teeratakulpisarn, Jamaree, Vesikari, Timo, Cohen, Rachel A

“…Abstract Background The true burden of lower respiratory tract infections (LRTIs) due to respiratory syncytial virus (RSV) remains unclear. This study aimed to…”
Get full text